SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections

CONCLUSION: These compounds could serve as scaffolds for further lead-structure optimization for desirable potency, a larger margin of safety, and better oral activity.PMID:38013440 | DOI:10.2174/0109298673271674231109052709
Source: Current Medicinal Chemistry - Category: Chemistry Authors: Source Type: research